KKR to Acquire Integer Holdings in $5.7 Bn All-Cash Deal
KKR will acquire medical device outsourcing company Integer Holdings in an all-cash deal valued at about $5.7 billion, paying $127 per share and assuming Integer’s outstanding debt, according to the companies. The offer implies a 4.78% premium to Integer’s Friday close. Integer shares rose 2.4% premarket. KKR said it will expand its healthcare portfolio.
How this was made
The 30-second read
Why it matters
KKR gains exposure to medical device outsourcing and components used in heart and pain therapies, while ITGR receives a cash buyout at a stated premium, creating a near-term valuation and deal-arbitrage catalyst.
Market read
This is a first-report M&A catalyst with explicit per-share cash terms and a stated premium, plus an immediate premarket reaction in the target stock.
What to watch
The article does not specify regulatory/closing timeline, termination fees, or financing structure; those details often drive deal-arb spreads more than the headline premium.
Background
The article frames the deal as part of ongoing private equity activity in healthcare and notes Integer’s prior activist pressure.
Ticker impact
KKR will acquire Integer Holdings in an all-cash deal valued at about $5.7 billion, expanding its healthcare portfolio.
Likely modest positive near-term sentiment for KKR, with follow-through dependent on deal terms, regulatory/closing risk, and financing details not provided here.
The article discloses deal size, all-cash structure, and KKR’s strategic rationale, but provides no financing, regulatory timeline, or closing conditions beyond debt assumption.
Integer Holdings agreed to be acquired by KKR for $127 per share in cash, implying a 4.78% premium to Friday’s close.
ITGR should remain supported by the offer premium, with volatility tied to deal certainty and any activist or regulatory developments.
The article provides the key tradable terms: $127/share cash, premium vs prior close, and that outstanding debt will be assumed, plus premarket reaction (+2.4%).
Market effects
Reinforces private equity appetite for healthcare services and medical device outsourcing, potentially supporting deal multiples in adjacent medtech supply chains.
Limited to US healthcare M&A sentiment; no specific regional operational impact described.
Global medtech component supply relationships are referenced, but no cross-border regulatory or demand shift is disclosed.
Counterpoint
Offer premium may compress if deal risk rises (regulatory scrutiny, financing, or activist pushback), so chasing the initial pop could be suboptimal.
Key entities
- acquirerKKR
Private equity firm announcing an all-cash acquisition of Integer Holdings valued at about $5.7 billion.
- targetInteger Holdings
Medical device outsourcing company receiving a $127 per share all-cash offer from KKR.
- activist investorIrenic Capital Management
Holds more than 3% of Integer and previously agreed to appoint two directors to the board.
